| Date | Ref. No. | Patent No. | Title |
| 1/11/2013 | E-222-2012/0 | | Transmission-Blocking Malaria Vaccine |
| 1/11/2013 | E-088-2012/0 | | Methods and Composition for Identification of Variants of JC Virus DNA; An Etiologic Agent for Progressive Multifocal Leukoencephalopathy (PML) |
| 1/11/2013 | E-273-2011/0 | | Cross-Reactive Dengue Fully Human Monoclonal Antibodies |
| 1/11/2013 | E-105-2011/0 | | Typhoid-Plague Bivalent Vaccine |
| 9/12/2012 | E-042-2008/0 | | Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studies |
| 8/31/2012 | E-078-2009/0 | | Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses |
| 7/31/2012 | E-216-2009/0 | | High Diversity/High Affinity Domain Antibody Library |
| 7/31/2012 | E-278-2009/0 | | Purified Saxitoxin for Food Safety Applications |
| 6/13/2012 | E-080-2011/0 | | Mouse Model of STAT5 for the Drug Screen and the Research of Cancer and Autoimmunity |
| 5/9/2012 | B-035-1998/0
B-035-1998/1
E-191-2011/0 | | Human DNA Polymerase Gamma for Testing the Effect of Drugs on Mitochondrial Function |
| 2/21/2012 | E-271-2011/0 | | Influenza Vaccine |
| 10/21/2011 | E-202-2011/1 | | Protease Deficient Bacillus anthracis with Improved Recombinant Protein Yield Capabilities |
| 9/29/2011 | E-231-2011/0 | | Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV) |
| 8/30/2011 | E-308-2008/0 | | A Vaccine for Shigella sonnei for Both Children and Adults |
| 8/30/2011 | E-255-2010/0 | | Transgenic Mice Expressing Human Arginase II Gene in Endothelium: Useful for Studying Atherosclerosis and Other Vasculopathies |
| 8/12/2011 | E-076-2011/0 | | Monoclonal Antibodies Against Poliovirus |
| 8/2/2011 | E-197-2010/0 | | Method to Create Vaccines for the Prevention of Flavivirus Infections by Targeting Micro-RNA |
| 7/26/2011 | E-032-2011/0 | | Multivalent Vaccines for Rabies Virus and Filoviruses |
| 4/29/2011 | E-067-2011/0 | | Improved Standard for Immune System Recovery Assay |
| 2/28/2011 | E-139-2006/0 | 8,337,860 | Development of Dengue Virus Type 3 Vaccine Candidates |
| 2/28/2011 | E-240-2007/0 | | Development of Antigenic Chimeric St. Louis Encephalitis Virus/Dengue Virus Type Four Recombinant Viruses (SLEV/DEN4) as Vaccine Candidates for the Prevention of Disease Caused by SLEV |
| 2/28/2011 | E-159-2007/3 | 8,337,854 | Monoclonal Antibodies Against Dengue and Other Viruses With Deletion in Fc Region |
| 2/28/2011 | E-031-2006/0 | | Chlamydia Vaccine |
| 2/28/2011 | E-066-2003/5 | 7,622,113
8,337,853 | Monoclonal Antibodies That Bind or Neutralize Dengue Virus |
| 2/28/2011 | E-022-2004/0 | 7,851,194 | Live-Attenuated West Nile Virus Vaccines with Improved Immune Responses |
| 2/28/2011 | E-151-2010/0 | | Erythroid Progenitor Cell Line for Hematological Disease Applications |
| 2/28/2011 | E-130-2002/0
E-189-2008/2
E-285-2002/0 | 7,485,306
7,741,437 | Vaccines Comprising Sand Fly Salivary Proteins for Control of Leishmania Infection |
| 10/29/2010 | E-156-2008/0 | | Insertion of Foreign Genes in Rubella Virus and their Stable Expression in a Live, Attenuated Viral Vaccine |
| 9/20/2010 | E-119-2009/0 | | A New “Destination” for Protein Expression: A Lentiviral Gateway® Destination Vector for High-Level Protein Expression (pDEST-673) |
| 9/9/2010 | E-221-2009/0 | | Chemical Attraction: Cell Lines Expressing the CXCR1 or CXCR2 Chemokine Receptors |
| 8/31/2010 | E-155-2010/0 | | An XMRV Tool Box: Expression Plasmids, Genes, and Proteins for All Components of the Xenotropic Murine Leukemia Virus-Related Virus (XMRV) |
| 8/23/2010 | E-055-2009/0 | | Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation |
| 7/12/2010 | E-106-2009/0 | | Mouse Model of Individual Unresponsive to Interferon |
| 6/21/2010 | E-107-2009/0 | | Hepatoma Cell Line That Can Be Infected with Both Hepatitis C and Human Immunodeficiency (HIV-1) Viruses |
| 6/16/2010 | E-278-2007/0 | | Attenuated Salmonella as a Delivery System for siRNA-Based Tumor Therapy |
| 6/16/2010 | E-343-2003/0 | | SAP/SH2D1A Knockout Mice: A Model for X-linked Lymphoproliferative Disease |
| 6/14/2010 | E-158-2007/3 | 8,298,541 | Live Attenuated Virus Vaccines for La Crosse Virus and Other Bunyaviridae |
| 6/14/2010 | E-142-2008/0 | | Humanized Monoclonal Antibodies that Specifically Bind Japanese Encephalitis Virus (JEV) and Their Use |
| 6/14/2010 | E-230-2002/2 | 7,482,133 | Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use |
| 6/14/2010 | E-189-1998/0 | | Inhibitors of Formation of Protease Resistant Prion Protein |
| 6/14/2010 | E-247-2002/1 | | Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis) |
| 6/10/2010 | E-040-1993/0 | 5,833,986
5,863,739 | Neutralizing Monoclonal Antibody To Human Alpha PDGF Receptors |
| 6/3/2010 | E-152-2009/0 | | qPCR Assay for Detection of JC Virus |
| 6/3/2010 | E-216-1994/0 | 6,057,346 | Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers |
| 3/1/2010 | E-107-1996/0 | 6,316,190 | Oligonucleotides Which Specifically Bind Retroviral Nucleocapsid Proteins |
| 2/12/2010 | E-279-2007/0 | | Alpha 1-3 N-Acetylgalactosaminyltransferases with Altered Donor and Acceptor Specificities, Compositions, and Methods of Use: Development of Pharmaceutical Agents and Improved Vaccines |
| 2/12/2010 | E-280-2007/0 | | Beta 1,4-Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use: Development of Pharmaceuticals and Improved Vaccines |
| 10/12/2009 | E-260-2009/0 | | Biological/Research Material for H1N1 Influenza Virus Vaccine Research |
| 10/7/2009 | E-328-2001/1 | | Use of CpG Oligodeoxynucleotides to Induce Epithelial Cell Growth |
| 9/21/2009 | E-299-2008/0 | | Improved Immunotherapeutic Compositions for Treatment, Diagnosis and Prevention of HIV |
| 9/3/2009 | E-169-2004/0
E-281-2005/0
E-318-2000/0 | | Rapid Diagnostic Applications of Phage |
| 8/31/2009 | E-125-2008/0 | | Monoclonal Antibodies That React With the Capsule of Bacillus anthracis |
| 8/14/2009 | E-063-2009/0 | | Antigen Mixtures for Serological Detection of HHV-8 Infection |
| 7/14/2009 | E-061-2009/0 | | Mouse Monoclonal Antibody Targeting Tetanus Toxin Heavy Chain Fragment C |
| 6/8/2009 | E-040-2005/0 | 7,625,736 | Methods for Preparing Immunogenic Conjugates |
| 5/15/2009 | E-129-2009/0 | | A549 Cells: A Well-Characterized Lung Carcinoma Cell Line Utilized for a Variety of Scientific Studies, including Adenovirus Production and Testing |
| 5/4/2009 | E-296-2008/0 | 8,053,422 | Anti-Cancer Oligodeoxynucleotides |
| 2/17/2009 | E-173-2008/0 | | Compositions and Methods for Vaccine and Virus Production |
| 10/1/2008 | E-145-2004/3 | 7,914,788 | Monoclonal Antibodies Against Orthopoxviruses |
| 10/1/2008 | E-183-2002/0 | 8,043,622 | Method of Treating Infectious and Inflammatory Lung Disease with Suppressive Oligonucleotides |
| 9/1/2008 | E-123-2007/0
E-146-2004/0 | 8,071,100 | Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF) |
| 9/1/2008 | E-268-2002/0 | 7,261,900 | Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines |
| 9/1/2008 | E-032-2008/0 | | Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax |
| 9/1/2008 | E-343-2002/0 | 7,803,386 | gammaPGA Conjugates for Eliciting Immune Responses Directed Against Bacillus anthracis and Other Bacilli |
| 8/1/2008 | E-141-2003/0 | 7,993,647 | Monoclonal Antibodies to HIV-1 Vpr |
| 10/1/2007 | E-263-2005/0 | 8,252,550 | Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections |
| 8/1/2007 | E-248-2006/0
E-248-2006/1 | | A Shuttle Plasmid, Recombinant MVA/HIV1 Clinical Vaccine Constructs and a Mechanism for Enhanced Stability of Foreign Gene Inserts by Codon Alternation and for Insertion of the Foreign Gene Between Two Vaccinia Virus Essential Genes |
| 8/1/2007 | E-068-1998/0 | 6,685,933
7,235,232 | Interferon Alpha Hybrids |
| 6/1/2007 | E-144-2004/0 | | Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus |
| 6/1/2007 | E-090-1996/0 | 7,151,087
7,374,872
8,198,042 | CC Chemokine Receptor 5 DNA, New Animal Models and Therapeutic Agents for HIV Infection |
| 6/1/2007 | E-300-2002/0 | | Development of a Novel High Throughput Assay to Measure Cell-Infection with Vaccinia Strains Expressing Reporter Genes |
| 4/1/2007 | E-131-2007/0 | | Biotinylated Alkylating Acridine for Pull-downs of Viral Pre-integration Complexes (PIC) or Other Cytosol Localized DNAs |
| 11/1/2006 | E-315-2006/0 | | A Simian Immunodeficiency Virus Expressing HIV-1 Reverse Transcriptase for the Study of Antiviral Drug Resistance in Macaques |
| 8/1/2006 | E-251-2006/0
E-251-2006/1 | | Molecules for Studying Cellular Immune Responses to Vaccines and Therapeutics |
| 5/1/2006 | E-075-2006/0 | | Monoclonal Antibody for Lyme Disease Diagnostic and Research |
| 2/1/2006 | E-174-1993/1
E-174-1993/2 | 6,001,555
6,989,263 | The CCHC Zinc Fingers of the Retroviral Nucleocapsid Protein Comprises a New Target Useful in Identification and Evaluation of Anti-HIV Therapeutics |
| 11/1/2005 | E-051-2005/0 | | Identification of a Fusion/Entry Receptor for Human Herpesvirus-8 |
| 10/1/2005 | E-321-2005/0
E-322-2005/0 | | Mouse Fibroblasts Stably Expressing C-Type Lectin Receptors DC-SIGN and L-SIGN |
| 9/1/2005 | E-184-2004/0 | | A Novel Amplification Method Permits Pathogens to be Detected with Microarrays |
| 6/1/2005 | E-043-2005/0 | | Cell Culture System for Efficient Expression of Self-Replicating Norwalk Virus |
| 4/1/2005 | E-176-2003/0 | | Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria |
| 2/1/2005 | E-195-2004/0 | | Monoclonal Antibody 90.12 Recognizes a Novel B Cell Surface Antigen Upregulated on Both Activated and Apoptotic Lymphocytes |
| 9/1/2004 | E-123-2004/0 | | Anti-Vaccinia Monoclonal Antibody |
| 5/1/2004 | E-131-2004/0 | | AT8, a Hybridoma Cell Line Producing a Monoclonal Antibody (MAb) Specific for Ly49G, a Mouse Natural Killer (NK) Cell Receptor |
| 1/1/2004 | E-041-2004/0 | | Codon-Optimization of the HIV-1 Vif Gene |
| 12/1/2003 | E-019-2004/0 | | Construction of Replication-Competent Chimeric Simian Immunodeficiency Virus (SIV) Human Immunodeficiency Virus Type 1 (HIV-1) Viruses that Replicate Using HIV-1 Reverse Transcriptase and Integrase (IN): A Model System for Development and Testing of Antiviral Agents for the Treatment of HIV-1 Infection |
| 5/1/2003 | E-161-2003/0 | | Flp-in T-Rex Jurkat Cell Line |
| 4/1/2003 | E-262-2002/0 | | Polyclonal Antibodies Specific to Phosphorylation and Acetylation Sites of Human p53 |
| 2/1/2003 | E-340-2002/0 | | 4G10, a Monoclonal Antibody Against the Chemokine Receptor CXCR4, Raised Against a Synthetic Peptide of 38 Residues in Length Derived from the N-terminal Sequence of CXCR4 |
| 2/1/2003 | E-249-2002/0 | | Decreased Side Effects of DRYVAX® Vaccination by Prior Immunization with Highly Attenuated Poxvirus in Immune-Compromised and Competent Hosts |
| 10/1/2002 | E-100-1999/0 | 7,084,266 | Cloned Genome of Infectious Hepatitis C Virus of Genotype 2a and Uses Thereof |
| 10/1/2002 | E-102-1999/0 | 7,009,044 | HCV/BVDV Chimeric Genomes and Uses Thereof |
| 10/1/2002 | E-173-1999/0 | 7,129,342 | Infectious cDNA Clone of GB Virus B and Uses Thereof |
| 10/1/1997 | E-059-1990/0 | 6,709,811 | Versatile Reagent For Detecting Murine Leukemia Viruses |
| 10/1/1997 | E-120-1993/0 | | Diagnostic Reagents And Vaccines For Multiple Genotypes Of Hepatitis C Virus |
| 11/1/1996 | E-017-1996/1 | 6,197,578 | Cells Expressing Both Human CD4 And A Human Fusion Accessory Factor Associated With HIV Infection |
| 8/1/1996 | E-183-1988/0 | 5,637,488 | Synthetic HIV Protease Gene And Method For Its Expression |
| 8/1/1996 | K-446-1987/0
K-446-1987/1 | | Human Immunodeficiency Virus Specific Proteolytic Enzyme And A Method For Its Synthesis And Renaturation |
| 2/1/1995 | E-202-1994/0 | 5,738,855 | Synthesis of Typhoid Fever Vaccine from a Plant or Fruit Polysaccharide |